Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells

A peptide comprising at least one NTP peptide selected from the group consisting of:

• a) The peptide represented by the amino acid sequence in SEQ ID NO. 8 (Ile-Asp-Gln-Gln-Val-Leu-Ser-Arg-Ile-Lys-Leu-Glu-Ile-Lys-Arg-Cys-Leu);
• b) The peptide represented by the amino acid sequence in SEQ ID NO. 9 (Met-Met-Val-Cys-Trp-Asn-Arg-Phe-Gly-Lys-Trp-Val-Tyr-Phe-Ile);
• c) The peptide represented by the amino acid sequence in SEQ ID NO. 10 (Ser-Ala-Ile-Phe-Asn-Phe-Gly-Pro-Arg-Tyr-Leu-Tyr-His-Gly-Val);
• d) The peptide represented by the amino acid sequence in SEQ ID NO. 11 (Pro-Phe-Tyr-Phe-Leu-Ile-Leu-Val-Arg-Ile-Ile-Ser-Phe-Leu-Ile);
• e) The peptide represented by the amino acid sequence in SEQ ID NO. 12 (Gly-Asp-Met-Glu-Asp-Val-Leu-Leu-Asn-Cys-Thr-Leu-Leu-Lys-Arg);
• f) The peptide represented by the amino acid sequence in SEQ ID NO. 13 (Ser-Ser-Arg-Phe-Arg-Phe-Trp-Gly-Ala-Leu-Val-Cys-Ser-Met-Asp);
• g) The peptide represented by the amino acid sequence in SEQ ID NO. 14 (Ser-Cys-Arg-Phe-Ser-Arg-Val-Ala-Val-Thr-Tyr-Arg-Phe-Ile-Thr);
• h) The peptide represented by the amino acid sequence in SEQ ID NO. 15 (Leu-Leu-Asn-Ile-Pro-Ser-Pro-Ala-Val-Trp-Met-Ala-Arg-Asn-Thr);
• i) The peptide represented by the amino acid sequence in SEQ ID NO. 16 (Met-Ala-Gln-Ser-Arg-Leu-Thr-Ala-The-Ser-Ala-Ser-Arg-Val-Gln);
• j) The peptide represented by the amino acid sequence in SEQ ID NO. 17 (Ala-Ile-Leu-Leu-Ser-Gln-Pro-Pro-Lys-Gln-Leu-Gly-Leu-Arg-Ala);
• k) The peptide represented by the amino acid sequence in SEQ ID NO. 18 (Pro-Ala-Asn-Thr-Pro-Leu-Ile-Phe-Val-Phe-Ser-Leu-Glu-Ala-Gly);
• l) The peptide represented by the amino acid sequence in SEQ ID NO. 19 (Phe-His-His-Ile-Cys-Gln-Ala-Gly-Leu-Lys-Leu-Leu-Thr-Ser-Gly);
• m) The peptide represented by the amino acid sequence in SEQ ID NO. 20 (Asp-Pro-Pro-Ala-Ser-Ala-Phe-Gln-Ser-Ala-Gly-Ile-Thr-Gly-Val);
• n) The peptide represented by the amino acid sequence in SEQ ID NO. 21 (Ser-His-Leu-Thr-Gln-Pro-Ala-Asn-Leu-Asp-Lys-Lys-Ile-Cys-Ser);
• o) The peptide represented by the amino acid sequence in SEQ ID NO. 22 (Asn-Gly-Gly-Ser-Cys-Tyr-Val-Ala-Gln-Ala-Gly-Leu-Lys-Leu-Leu-Ala-Ser-Cys-Asn-Pro-Ser-Lys);
• p) The peptide represented by the amino acid sequence in SEQ ID NO. 23 (Met-Trp-Thr-Leu-Lys-Ser-Ser-Leu-Val-Leu-Leu-Leu-Cys-Leu-Thr);
• q) The peptide represented by the amino acid sequence in SEQ ID NO. 24 (Cys-Ser-Tyr-Ala-Phe-Met-Phe-Ser-Ser-Leu-Arg-Gln-Lys-Thr-Ser);
• r) The peptide represented by the amino acid sequence in SEQ ID NO. 25 (Glu-Pro-Gln-Gly-Lys-Val-Pro-Cys-Gly-Glu-His-Phe-Arg-Ile-Arg);
• s) The peptide represented by the amino acid sequence in SEQ ID NO. 26 (Gln-Asn-Leu-Pro-Glu-His-Thr-Gln-Gly-Trp-Leu-Gly-Ser-Lys-Trp);
• t) The peptide represented by the amino acid sequence in SEQ ID NO. 27 (Leu-Trp-Leu-Leu-Phe-Ala-Val-Val-Pro-Phe-Val-Ile-Leu-Lys-Cys);
• u) The peptide represented by the amino acid sequence in SEQ ID NO. 28 (Gln-Arg-Asp-Ser-Glu-Lys-Asn-Lys-Val-Arg-Met-Ala-Pro-Phe-Phe);
• v) The peptide represented by the amino acid sequence in SEQ ID NO. 29 (Leu-His-His-Ile-Asp-Ser-Ile-Ser-Gly-Val-Ser-Gly-Lys-Arg-Met-Phe);
• w) The peptide represented by the amino acid sequence in SEQ ID NO. 30 (Glu-Ala-Tyr-Tyr-Thr-Met-Leu-His-Leu-Pro-Thr-Thr-Asn-Arg-Pro);
• x) The peptide represented by the amino acid sequence in SEQ ID NO. 31 (Lys-Ile-Ala-His-Cys-Ile-Leu-Phe-Asn-Gln-Pro-His-Ser-Pro-Arg);
• y) The peptide represented by the amino acid sequence in SEQ ID NO. 32 (Ser-Asn-Ser-His-Ser-His-Pro-Asn-Pro-Leu-Lys-Leu-His-Arg-Arg);
• z) The peptide represented by the amino acid sequence in SEQ ID NO. 33 (Ser-His-Ser-His-Asn-Arg-Pro-Arg-Ala-Tyr-Ile-Leu-Ile-Thr-Ile);
• aa) The peptide represented by the amino acid sequence in SEQ ID NO. 34 (Leu-Pro-Ser-Lys-Leu-Lys-Leu-Arg-Thr-His-Ser-Gln-Ser-His-His);
• bb)The peptide represented by the amino acid sequence in SEQ ID NO. 35 (Asn-Pro-Leu-Ser-Arg-Thr-Ser-Asn-Ser-Thr-Pro-Thr-Asn-Ser-Phe-Leu-Met-Thr-Ser-Ser-Lys-Pro-Arg);
• cc) The peptide represented by the amino acid sequence in SEQ ID NO. 36 (Ser-Ser-Ser-Leu-Gly-Leu-Pro-Lys-Cys-Trp-Asp-Tyr-Arg-His-Glu);
• dd) The peptide represented by the amino acid sequence in SEQ ID NO. 37 (Leu-Leu-Ser-Leu-Ala-Leu-Met-Ile-Asn-Phe-Arg-Val-Met-Ala-Cys);
• ee) The peptide represented by the amino acid sequence in SEQ ID NO. 38 (Thr-Phe-Lys-Gln-His-Ile-Glu-Leu-Arg-Gln-Lys-Ile-Ser-Ile-Val);
• ff) The peptide represented by the amino acid sequence in SEQ ID NO. 39 (Pro-Arg-Lys-Leu-Cys-Cys-Met-Gly-Pro-Val-Cys-Pro-Val-Lys-Ile);
• gg)The peptide represented by the amino acid sequence in SEQ ID NO. 40 (Ala-Leu-Leu-Thr-Ile-Asn-Gly-His-Cys-Thr-Trp-Leu-Pro-Ala-Ser);
• hh)The peptide represented by the amino acid sequence in SEQ ID NO. 41 (Met-Phe-Val-Phe-Cys-Leu-Ile-Leu-Asn-Arg-Glu-Lys-Ile-Lys-Gly);
• ii) The peptide represented by the amino acid sequence in SEQ ID NO. 42 (Gly-Asn-Ser-Ser-Phe-Phe-Leu-Leu-Ser-Phe-Phe-Phe-Ser-Phe-Gln);
• jj) The peptide represented by the amino acid sequence in SEQ ID NO. 43 (Asn-Cys-Cys-Gln-Cys-Phe-Gln-Cys-Arg-Thr-Thr-Glu-Gly-Tyr-Ala);
• kk)The peptide represented by the amino acid sequence in SEQ ID NO. 44 (Val-Glu-Cys-Phe-Tyr-Cys-Leu-Val-Asp-Lys-Ala-Ala-Phe-Glu-Cys-Trp-Trp-Phe-Tyr-Ser-Phe-Asp-Thr);
• ll) The peptide represented by the amino acid sequence in SEQ ID NO. 45 (Met-Glu-Pro-His-Thr-Val-Ala-Gln-Ala-Gly-Val-Pro-Gln-His-Asp);
• mm) The peptide represented by the amino acid sequence in SEQ ID NO. 46 (Leu-Gly-Ser-Leu-Gln-Ser-Leu-Leu-Pro-Arg-Phe-Lys-Arg-Phe-Ser);
• nn)The peptide represented by the amino acid sequence in SEQ ID NO. 47 (Cys-Leu-Ile-Leu-Pro-Lys-Ile-Trp-Asp-Tyr-Arg-Asn-Met-Asn-Thr);
• and
• oo) The peptide represented by the amino acid sequence in SEQ ID NO. 48 (Ala-Leu-Ile-Lys-Arg-Asn-Arg-Tyr-Thr-Pro-Glu-Thr-Gly-Arg-Lys-Ser).